Dalya Güriş

7.1k total citations · 3 hit papers
42 papers, 4.5k citations indexed

About

Dalya Güriş is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Dalya Güriş has authored 42 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Epidemiology, 14 papers in Infectious Diseases and 9 papers in Surgery. Recurrent topics in Dalya Güriş's work include Virology and Viral Diseases (11 papers), Herpesvirus Infections and Treatments (11 papers) and Clostridium difficile and Clostridium perfringens research (11 papers). Dalya Güriş is often cited by papers focused on Virology and Viral Diseases (11 papers), Herpesvirus Infections and Treatments (11 papers) and Clostridium difficile and Clostridium perfringens research (11 papers). Dalya Güriş collaborates with scholars based in United States, Canada and Australia. Dalya Güriş's co-authors include Jane F. Seward, Sandra S. Chaves, Mona Marin, Scott Schmid, Edson Duarte Moreira, Scott Vuocolo, Richard M. Haupt, Stephen E. Goldstone, Heiko Jessen and Carlos Aranda and has published in prestigious journals such as New England Journal of Medicine, JAMA and Gastroenterology.

In The Last Decade

Dalya Güriş

42 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males

2011 821 citations Anna R. Giuliano, Joel M. Palefsky et al. New England Journal of Medicine profile →
Prevention of Varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

1996 785 citations Dalya Güriş, Sandra S. Chaves et al. profile →
HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia

2011 650 citations Joel M. Palefsky, Anna R. Giuliano et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Dalya Güriş

Since Specialization

Citations

This map shows the geographic impact of Dalya Güriş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dalya Güriş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dalya Güriş more than expected).

Fields of papers citing papers by Dalya Güriş

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dalya Güriş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dalya Güriş. The network helps show where Dalya Güriş may publish in the future.

Co-authorship network of co-authors of Dalya Güriş

This figure shows the co-authorship network connecting the top 25 collaborators of Dalya Güriş. A scholar is included among the top collaborators of Dalya Güriş based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dalya Güriş. Dalya Güriş is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	In RRP, serologic response to HPV is frequently absent and slow to develop 2020 ·PLoS ONE ·Farrel J. Buchinsky, (unknown), (unknown), Craig S. Derkay, John E. McClay, Robert W. Bastian, Charles M. Myer, (unknown), Dalya Güriş	11
2	Bezlotoxumab for prevention of Clostridium difficile infection recurrence: Distinguishing relapse from reinfection with whole genome sequencing 2019 ·Anaerobe ·Zhen Zeng, Hailong Zhao, Marcus Dörr, Judong Shen, Mark H. Wilcox, Ian R. Poxton, Dalya Güriş, Junhua Li, Peter Shaw	6
3	Antibodies to Toxin B Are Protective AgainstClostridium difficileInfection Recurrence 2016 ·Clinical Infectious Diseases ·Swati B. Gupta, Vinay Mehta, Erik R. Dubberke, Xuemei Zhao, Marcus Dörr, Dalya Güriş, Deborah C. Molrine, Mark D. Leney, Mark A. Miller, (unknown), T. Christopher Mast	55
4	599 The Monoclonal Antibody, Bezlotoxumab Targeting C. difficile Toxin B Shows Efficacy in Preventing Recurrent C. difficile Infection (CDI) in Patients at High Risk of Recurrence or of CDI-Related Adverse Outcomes 2016 ·Gastroenterology ·Ciarán P. Kelly, Dale N. Gerding, Galia Rahav, Christine H. Lee, Erik R. Dubberke, (unknown), Karen Eves, Alison Pedley, Robert Tipping, Dalya Güriş, Nicholas A. Kartsonis, Marcus Dörr	6
5	Quadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in males 2013 ·Vaccine ·Stephen E. Goldstone, Heiko Jessen, Joel M. Palefsky, Anna R. Giuliano, Edson Duarte Moreira, Eftyhia Vardas, Carlos Aranda, Richard J. Hillman, Daron G. Ferris, François Coutlée, J. Brooke Marshall, Scott Vuocolo, Richard M. Haupt, Dalya Güriş, Elizabeth Garner	38
6	Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males breakdown → 2011 ·New England Journal of Medicine ·Anna R. Giuliano, Joel M. Palefsky, Stephen E. Goldstone, Edson Duarte Moreira, Mary E. Penny, Carlos Aranda, Eftyhia Vardas, Harald Moi, Heiko Jessen, Richard J. Hillman, Yen-Hwa Chang, Daron Ferris, Danielle Rouleau, Janine T. Bryan, J. Brooke Marshall, Scott Vuocolo, Eliav Barr, David Radley, Richard M. Haupt, Dalya Güriş	821
7	Safety and reactogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 viral-like-particle vaccine in older adolescents and young adults 2011 ·Human Vaccines ·Edson Duarte Moreira, Joel M. Palefsky, Anna R. Giuliano, Stephen E. Goldstone, Carlos Aranda, Heiko Jessen, Richard J. Hillman, Daron Ferris, François Coutlée, Eftyhia Vardas, J. Brooke Marshall, Scott Vuocolo, Richard M. Haupt, Dalya Güriş, Elizabeth Garner	27
8	HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia breakdown → 2011 ·New England Journal of Medicine ·Joel M. Palefsky, Anna R. Giuliano, Stephen E. Goldstone, Edson Duarte Moreira, Carlos Aranda, Heiko Jessen, Richard J. Hillman, Daron Ferris, François Coutlée, Mark H. Stoler, J. Brooke Marshall, David Radley, Scott Vuocolo, Richard M. Haupt, Dalya Güriş, Elizabeth Garner	650
9	An Open-Label, Randomized, Multicenter Study of the Safety, Tolerability, and Immunogenicity of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine Given Concomitantly With Diphtheria, Tetanus, Pertussis, and Poliomyelitis Vaccine in Healthy Adolescents 11 to 17 Years of Age 2010 ·The Pediatric Infectious Disease Journal ·Timo Vesikari, Pierre Van Damme, (unknown), (unknown), David Radley, (unknown), Scott Vuocolo, Richard M. Haupt, Dalya Güriş	37
10	Changing Varicella Epidemiology in Active Surveillance Sites—United States, 1995–2005 2008 ·The Journal of Infectious Diseases ·Dalya Güriş, Aisha O. Jumaan, Laurene Mascola, Barbara Watson, John H. Zhang, Sandra S. Chaves, Paul Gargiullo, Dana Perella, Rachel Civen, Jane F. Seward	161
11	Varicella Outbreak Reporting, Response, Management, and National Surveillance 2008 ·The Journal of Infectious Diseases ·Jessica Leung, (unknown), Adriana Lopez, Ismael R. Ortega‐Sanchez, Rafael Harpaz, Dalya Güriş, Jane F. Seward	12
12	An Economic Analysis of the Universal Varicella Vaccination Program in the United States 2008 ·The Journal of Infectious Diseases ·Fangjun Zhou, Ismael R. Ortega‐Sanchez, Dalya Güriş, Abigail Shefer, Tracy A. Lieu, Jane F. Seward	65
13	Challenges to Implementing Second‐Dose Varicella Vaccination during an Outbreak in the Absence of a Routine 2‐Dose Vaccination Requirement—Maine, 2006 2008 ·The Journal of Infectious Diseases ·Amy A. Parker, Meredith A. Reynolds, Jessica Leung, Meredith Anderson, Araceli Rey, Ismael R. Ortega‐Sanchez, D. Scott Schmid, Dalya Güriş, Kathleen F. Gensheimer	28
14	Loss of Vaccine-Induced Immunity to Varicella over Time 2007 ·New England Journal of Medicine ·Sandra S. Chaves, Paul Gargiullo, John H. Zhang, Rachel Civen, Dalya Güriş, Laurene Mascola, Jane F. Seward	227
15	Genetic characterization of measles viruses isolated in Turkey during 2000 and 2001 2005 ·Virology Journal ·Gülay Korukluoğlu, Stephanie Liffick, Dalya Güriş, Fumio Kobune, Paul A. Rota, William J. Bellini, Ali Ceylan, Melikşah Ertem	15
16	Establishment of Diagnostic Cutoff Points for Levels of Serum Antibodies to Pertussis Toxin, Filamentous Hemagglutinin, and Fimbriae in Adolescents and Adults in the United States 2004 ·Clinical and Vaccine Immunology ·Andrew L. Baughman, Kristine M. Bisgard, Kathryn M. Edwards, Dalya Güriş, Michael D. Decker, Kathy L. Holland, Bruce D. Meade, Freyja Lynn	109
17	Measles Epidemiology and Elimination Strategies in Turkey 2003 ·The Journal of Infectious Diseases ·Dalya Güriş, Yıldırım A. Bayazit, (unknown), (unknown), (unknown), (unknown), (unknown)	24
18	Measles outbreaks in Micronesia, 1991 to 1994 1998 ·The Pediatric Infectious Disease Journal ·Dalya Güriş, Steven B. Auerbach, Charles Vitek, (unknown), (unknown), (unknown), (unknown), (unknown), Robert L Haddock, Jennifer S. Rota, Paul A. Rota, Janet L. Heath, Stephen C. Redd	11
19	Effectiveness of the Pertussis Vaccination Program as Determined by Use of the Screening Method: United States, 1992–1994 1997 ·The Journal of Infectious Diseases ·Dalya Güriş, Peter M. Strebel, Raffi Tachdjian, Barbara H. Bardenheier, Melinda Wharton, Stephen C. Hadler	24
20	Measles Vaccine Effectiveness and Duration of Vaccine-induced Immunity in the Absence of Boosting from Exposure to Measles Virus 1996 ·The Pediatric Infectious Disease Journal ·Dalya Güriş, (unknown), John C. Watson, William Atkinson, Janet L. Heath, William J. Bellini, (unknown)	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact